Diagnostic procedures by Italian general practitioners in response to lower urinary tract symptoms in male patients: a prospective study

References

• Madersbacher S, Haidinger G, Temml C, Schmidbauer CP. Prevalence of lower urinary tract symptoms in Austria as assessed by an open survey of 2096 men. Eur Urol 1998;34:136–41
   PubMed Web of Science ®Google Scholar
• Berges RR, Pientka L, Hofner K, et al. Male lower urinary tract symptoms and related health care seeking in Germany. Eur Urol 2001;39:682–7
   PubMed Web of Science ®Google Scholar
• Sonke GS, Kolman D, de la Rosette JJ, et al. Prevalence of lower urinary symptoms in men and influence on their quality of life: Boxmeer Study [in Dutch] Ned Tijdschr Geneeskd 2000;30(144):2558–63
   Google Scholar
• Logie JW, Clifford GM, Farmer RD, Meesen BP. Lower urinary tract symptoms suggestive of benign prostatic obstruction – Triumph: the role of general practice databases. Eur Urol 2001;39 (Suppl 3):42–7
   PubMed Web of Science ®Google Scholar
• Bertaccini A, Vassallo F, Martino F, et al. Symptoms, bothersomeness and quality of life in patients with LUTS suggestive of BPH. Eur Urol 2001;40 (Suppl 1):13–8
   PubMed Web of Science ®Google Scholar
• Vercelli M, Quaglia A, Marani E, Parodi S. Prostate cancer incidence and mortality trends among elderly and adult Europeans. Crit Rev Oncol Hematol 2000;35:133–44
   PubMed Web of Science ®Google Scholar
• IMS agency Italy. Servizio Prescrizioni Mediche, Report. 2000
   Google Scholar
• United Nations. World Population Prospects: The 2000 Revision Highlights. February 2001, p. 47–50
   Google Scholar
• Chisholm GD, Carne SJ, Fitzpatrick JM, et al. Prostate disease: management options for the primary healthcare team. Report of a working party of the British Prostate Group. Postgrad Med J 1995;71:136–42
   PubMed Web of Science ®Google Scholar
• Klomp ML, Rosmalen CF, Romeijnders AC, et al. Benign prostatic hyperplasia recommendations for transmural care [in Dutch]. Ned Tijdschr Geneeskd 1998;142:2563–8
   PubMedGoogle Scholar
• Padilla Leon M, Marchal Escalona C, Caballero Alcantara J, et al. Shared care in benign prostatic hyperplasia. First national experience [in Spanish] Actas Urol Esp. 1998;22:478–83
   PubMedGoogle Scholar
• Kirby R, Fitzpatrick J, Kirby M, Fitzpatrick A. Shared care for prostatic diseases, 2nd ed., Oxford: Isis Medical Media Ltd; 2000
   Google Scholar
• Jimenez Cruz JF, Rodriguez Vallejo JM, Conejero J, et al. The urologist and prostatic disease. National survey. Members of the Spanish Council on Prostatic Health [in Spanish]. Actas Urol Esp 1996;20:630–5
   Google Scholar
• Coeurdacier P, Staerman F, Thoquenne G, et al. General practitioners’ approach to urination disorders in men over the age of 50. A survey of 250 physicians in Brittany [in French]. Prog Urol 1996;6: 52–9
   Google Scholar
• Fawzy A, Fontenot C, Guthrie R, Baudier MM. Practice patterns among primary care physicians in benign prostatic hyperplasia and prostate cancer. Fam Med 1997;29:321–5
   PubMedGoogle Scholar
• Bruskewitz R. Management of symptomatic BPH in the US: who is treated and how? Eur Urol 1999;36(Suppl 3):7–13
   PubMed Web of Science ®Google Scholar
• Ewyn GJ, Rix A, Matthews P, Stott NC. Referral for ‘prostatism’: developing a ‘performance indicator’ for the threshold between primary and secondary care? Fam Pract 1999;16:140–2
   PubMed Web of Science ®Google Scholar
• Lukacs B. Management of symptomatic BPH in France: who is treated and how? Eur Urol 1999;36(Suppl 3):14–20
   PubMed Web of Science ®Google Scholar
• McNicholas TA. Management of symptomatic BPH in the UK: who is treated and how? Eur Urol 1999;36(Suppl 3):33–9
   PubMed Web of Science ®Google Scholar
• Roehrborn CG, Bartsch G, Kirby R, et al. Guidelines for the diagnosis and treatment of benign prostatic hyperplasia: a comparative, international overview. Urology 2001;58:642–50
   PubMed Web of Science ®Google Scholar
• de la Rosette JMCH, van der Schoot DKE, Debruyne FMJ. Recent developments in guidelines on benign postatic hyperplasia. Curr Opin Urol 2002;12:3–6
   PubMedGoogle Scholar
• American Urological Association. Guideline on the management of benign prostatic hyperplasia (BPH), 2003, available from www.auanet.org/timssnet/products/guidelines/bph_management [accessed 22 December 2003]
   Google Scholar
• De la Rosette J, Alivizatos G, Madersbacher S, et al: Guidelines on benign prostatic hyperplasia. In: EAU Healthcare Office, editor. European Association of Urology Guidelines, update. Arnhem: European Association of Urology; 2002
   Google Scholar
• Gattellari M, Young JM, Ward JE. GP and patient predictors of PSA screening in Australian general practice. Fam Pract 2003;20:294–303
   Google Scholar
• Anonymous. Prostate-specific antigen (PSA) best practice policy. American Urological Association (AUA). Oncology (Huntington) 2000;14:267–72, 277–8, 280 passim
   Google Scholar
• Chatelain C., Denis L, Foo KT, Khoury S, Mc Connell J, editors. Benign prostatic hyperplasia, 5th International Consultation on BPH. Health Publication Ltd; 2001
   Google Scholar
• Hood HM, Burgess PA, Holtgrewe HL, et al. Adherence to Agency for Health Care Policy and Research guidelines for benign prostatic hyperplasia. J Urol 1997;158:1417–21
   PubMed Web of Science ®Google Scholar
• Collins MM, Barry MJ, Bin L, et al. Diagnosis and treatment of benign prostatic hyperplasia: practice patterns of primary care physicians. J Gen Intern Med 1997;12:224–9
   PubMed Web of Science ®Google Scholar
• Kim HL, Benson DA, Stern SD, Gerber GS. Practice trends in the management of prostate disease by family practice physicians and general internists: an internet-based survey. Urology 2002;59:266–71
   PubMed Web of Science ®Google Scholar